Aspirin increases the risk of bowel cancer in some

US study found that the use of aspirin regularly can increase the risk of bowel cancer, although as noted by previous studies that limits certain types of cancer, as well as its usefulness in reducing heart attacks

Concluded experiments were conducted on 19 thousand Euro to it despite the fact that regular use of aspirin reduced the risk of bowel cancer, it varies depending on the status of the gene for each person

Among those carrying two Jinyin rare, there are people from all nine appeared that aspirin did not reduce or increase the risk of the disease he has. For those who hold these two categories of genotypes rare, the use of aspirin was associated with a higher risk bowel cancer or colon or rectum by up to one in every 25

US researchers said that the study published Journal of the American Medical Association (JAMA) help identify people who can benefit from taking aspirin and anti-inflammatory drugs to reduce the risk of bowel cancer.

A previous study showed that the potential benefit of aspirin in reducing the risk of colon cancer almost exclusively on the genes of people who secrete high levels of the enzyme, "15", adding that the owners of low levels of this enzyme do not benefit at all from aspirin

The identification of people who can benefit from aspirin is important, because eating involves the risk of ulcers and gastrointestinal bleeding, which may be fatal

And bowel cancer affects 16 thousand people a year in Britain, making it the second most deadly cancer in the country. As is diagnosed 40 thousand cases of the disease annually each year in the United Kingdom, making it the fourth most prevalent types of cancer